Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AAM Warns Over Weakening 180-Day Incentive
Mar 20 2019
•
By
David Wallace
Amending 180-Day Exclusivity Risks Weakening The Incentive • Source: Shutterstock
More from Regulation
More from Policy & Regulation